Strikingly, this cancer cell subpopulation displayed enhanced expression of Bcl-xL, strongly suggesting that the upregulation of this antiapoptotic protein also supports the survival of invasive cancer cells within patients. The gene discussed is BCL2L1; the disease is cancer.